RxSight (RXST) Other financing activities (2020 - 2026)
RxSight (RXST) posted Other financing activities of $100000.0 for Q1 2026, up 114.29% on a QoQ basis from -$700000.0 in Q2 2025, and down 85.71% year-over-year from $700000.0 in Q1 2025.
RxSight (RXST) Other financing activities (2020 - 2026) Analysis & Trends
RxSight's Other financing activities history runs 7 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- Quarterly Other financing activities fell 85.71% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$600000.0 (down 100.61% YoY) and the FY2024 annual result came in at $108.1 million, up 100.0% from the prior year.
- Other financing activities was $100000.0 for Q1 2026 at RxSight, up from -$700000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $97.9 million in Q2 2024 and bottomed at -$700000.0 in Q2 2025.
- A 5-year average of $20.3 million and a median of $504000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities plunged 4300.0% — and 2023, when it surged 17448.7%.
- RxSight's Other financing activities stood at -$308000.0 in 2022, then soared by 17648.7% to $54.0 million in 2023, then soared by 81.13% to $97.9 million in 2024, then tumbled by 100.72% to -$700000.0 in 2025, then jumped by 114.29% to $100000.0 in 2026.
- Business Quant data shows RXST's Other financing activities at $100000.0 in Q1 2026, -$700000.0 in Q2 2025, and $700000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Jun 30, 2025 | -700,000.00 |
| Jun 30, 2025 | -700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Jun 30, 2024 | 97.90 Mn |
| Jun 30, 2024 | 97.90 Mn |
| Mar 31, 2024 | 10.20 Mn |
| Mar 31, 2024 | 10.20 Mn |
| Mar 31, 2023 | 54.05 Mn |
| Mar 31, 2023 | 54.05 Mn |
| Jun 30, 2022 | -308,000.00 |
| Jun 30, 2022 | -308,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Sep 30, 2021 | -410,000.00 |
| Sep 30, 2021 | -410,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Jun 30, 2021 | -7,000.00 |